A Study to Evaluate the Safety and Tolerability of EP0089

Clinical trial NCT07030478 · NOT_YET_RECRUITING

Trial details

NCT number: NCT07030478
Sponsor: Ellipses Pharma
Status: NOT_YET_RECRUITING
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Solid Cancers Solid Tumours

Start date: 2025-09-01
Primary completion: 2028-03-01
Enrollment: 190

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.